In March 2017, MesotheliomaHelp reported on the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH) clinical trial that was opened to thousands of cancer patients for treatments based on the genetic makeup of their tumors. Last week, researchers presented early results of the “largest precision medicine trial of its kind” that point to increased interest in personalized treatment for all cancer patients, including mesothelioma patients. One target for the trial is for at least 25 percent of the total patients enrolled to have rare or uncommon cancers, and, according to the NCI-Match website, the trial has exceeded this goal with about 60% […]
The post Early Results of NCI-Match Trial Bring Hope of Better Treatment Options for Mesothelioma Patients appeared first on MesotheliomaHelp.org.
from Blog – MesotheliomaHelp.org https://ift.tt/2JxYEMu
via IFTTT
No comments: